期刊文献+

磷酸酶基因、核因子-κBp65、Survivin蛋白在子宫内膜样腺癌中的表达及其临床意义 被引量:1

Expression of PTEN, NF-κB p65 and Survivin in endometrial carcinoma and its clinical significance
原文传递
导出
摘要 目的探讨磷酸酶基因(PTEN)、核因子(NF-κB p65)及凋亡抑制蛋白Survivin基因在子宫内膜样腺癌中的表达及其在子宫内膜样腺癌的发生、发展中的作用。方法采用SP免疫组织化学法检测63例子宫内膜样腺癌、20例正常增生期子宫内膜组织中PTEN、NF-κB p65及Survivin蛋白的表达。结果子宫内膜样腺癌与正常增生期子宫内膜组织中PTEN、NF-κB p65及Survivin蛋白表达的阳性率差异有统计学意义(P〈0.01)。PTEN表达与子宫内膜样腺癌分化程度呈正相关(P〈0.001),与淋巴结转移及TNM分期呈负相关(P〈0.005),NF-κB p65的表达与子宫内膜样腺癌分化程度呈负相关(P〈0.05),与浸润深度、淋巴结转移及TNM分期呈正相关(P〈0.05)。Survivin与子宫内膜样腺癌与浸润深度、淋巴结转移及TNM分期呈正相关(P〈0.05)。结论PTEN、NF-κB p65及Survivin在子宫内膜腺癌的发生、发展中起着不同程度的作用,联合检测PTEN、NF-κB p65及Survivin对研究子宫内膜腺癌的发生、发展、早期诊断及预后评估有一定的参考价值。 Objective To explore the expression of PTEN, NF-κB p65 and Survivin protein and the influence in the genesis and development of endometrial carcinoma(EC). Methods The expression of PTEN, NF-κB and Survivin in 63 cases of EC and 20 cases normal endometrial tissue specimens were detected by immunohistochemistry. Results There were obvious differences among the positive rates of PTEN, N-κB p65 and Survivin protein in EC compared with in normal endometrial tissue specimens (P 〈0.001). The clinieopathological characteristics of endometrial carcinoma with PTEN, NF-κB p65 and Survivin were as follows: the expression of PTEN gene was positively correlated with the degree of histological differentiation(P 〈 0.001), and it was negatively correlated with lymph node metastasis and TNM (P 〈0.005). There was inverse correlation between the expression of NF-κB p65 gene and the degree of histological differentiation(P 〈0.05). It was positively correlated with lymph node metastasis, deep myometrial invasion and TNM in EC (P 〈0.05). The expression of Survivin was positively correlated with the clinical stage and lymph node metastasis and deep myometrial invasion in EC (P 〈0.05). Conclusion There are different extent action of PTEN, NF-κB p65 and Survivin significantly in genesis and development of EC. Detection of PTEN combined with NF-κB p65 and Survivin is valuable for early diagnosing and evaluating malignancy extent of EC.
作者 张玲 李美蓉
出处 《肿瘤研究与临床》 CAS 2008年第12期820-822,共3页 Cancer Research and Clinic
关键词 子宫内膜样 PTEN磷酸水解酶 NF-κB p65亚基 凋亡抑制蛋白质类 Carcinoma, endometrioid PTEN phosphohydrolase NF-kappa B, p65 subunit Inhibitor of apoptosis proteins
  • 相关文献

参考文献8

  • 1Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphalase gene mutated in human brain,breast, and prostate cancer [J]. Science, 1997, 275(5308): 1943-1947.
  • 2Kinzler KW, Vogelstein B. Cancer suseeptibility genes. Gatekeepers and caretakers[J]. Nature, 1997, 386(6627): 761-763.
  • 3李淑敏,章文华,赵晓航.子宫内膜癌组织中抑癌基因PTEN的研究现状[J].中华妇产科杂志,2002,37(12):754-756. 被引量:15
  • 4Garg A, Aggarwal BB, et al. Nuclear transcription factor-kappa B as a target for cancer drug development[J]. Leukemia, 2002, 16(6): 1053.
  • 5Gustin JA, Machama T, Dixon JE, et al. The PTEN tumor suppressor protein inhibits tumor necrosis factor-inducted nuclear faclor kappa B activity[J]. J Biol Chem, 2001,276(29): 27740-27744.
  • 6Nishiu MM, Unoki M, Ono K, et al. Growth and gene expression profile analyses of endometrial cancer cells expressing exogenous PTEN[J]. Cancer Res, 2001, 61(9): 3741-3749.
  • 7Carter BZ, Milella M, Ahieri DC, et al. Cytokine regulated expression of surviving in myeloid leukemia[J]. Blood, 2001,97(9): 2784-2790.
  • 8Tracey L, Pe'rez-Rosado A, Artiga M J, et al. Expression of the NF-KappB targets bel-2 and BIRC5/Survivn characterizes small B-cell and aggressive B-cell lymphomas,respectively [J]. J Pathol, 2005, 206(2): 123-134.

二级参考文献17

  • 1Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275:1943-1947.
  • 2Lee JO, Yang H, Georgescu MM, et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell, 1999,99:323-334.
  • 3Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell, 2000,100:387-390.
  • 4Hopkin K. A surprising function for the PTEN tumor suppressor. Science, 1998,282:1027,1029-1030.
  • 5Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 1998, 280:1614-1617.
  • 6Ali IU. Gatekeeper for endometrium: the PTEN tumor suppressor gene. J Natl Cancer Inst, 2000,92:861-863.
  • 7Minaguchi T, Yoshikawa H, Oda K, et al. PTEN mutation located only outside exons 5, 6, and 7 is an independent predictor of favorable survival in endometrial carcinomas. Clin Cancer Res, 2001,7:2636-2642.
  • 8Gunter Kieback D, Fischer DC. Gene expression profile in endometrioid endometrial carcinoma. Gynecol Oncol, 2001,83:175-176.
  • 9Bussaglia E, del Rio E, Matias-Guiu X, et al. PTEN mutations in endometrial carcinomas: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol, 2000,31:312-317.
  • 10Hirai Y, Tanaka N, Furuta R, et al. Somatic mutations of the PTEN/NMAC1 gene associated with frequent chromosomal loss detected using comparative genomic hybridization in endometrial cancer. Gynecol Oncol, 2001,83:81-88.

共引文献14

同被引文献28

  • 1Tavassoli FA.乳腺及女性生殖器官肿瘤病理学和遗传学[M].程虹等译.北京:人民卫生出版社,2006.312.
  • 2Gologan A, Krasinskas A, Hunt J, et al. performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability[J]. Arch Pathol Lab Med, 2005, 129: 1390-1397.
  • 3Boland C, Koi M, Chang D, et al. The biochemical basis of mierosatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome[J]. Fam Cancer, 2008, 7: 41-52.
  • 4Thibodeau S, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon[J]. Science, 1993, 260: 816-819.
  • 5Geisler J, Goodheart M, Sood A, et al. mismatch repair geneexpression defects contribute to microsatellite instability in ovarian carcinoma[J]. Cancer, 2003, 98: 2199-2206.
  • 6Shannon C, Kirk J, Barnetson R, et al. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium [J]. Clin Cancer Res, 2003, 9: 1387-1392.
  • 7Yao Y, Tao H, Kim J, et al. Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell [J]. Lab Invest, 2004, 84: 915-922.
  • 8Marani C, Alvino E, Caporali S, et al. DNA mismatch repair protein expression and microsatellite instability . in primary mucosal melanomas of the head and neck[J]. Histopathology, 2007, 50: 780- 788.
  • 9Nunn J, Nagini S, Risk J, et al. Allelic imbalance at the DNA mismatch repair loci, hMSH2, hMLH1, hPMS1, hPMS2 and hMSH3, in squamous cell carcinoma of the head and neck [J]. Oral Oncol, 2003, 39: 115-129.
  • 10Solomon C, Pho LN, Butt R, Current status of genetic testing for colorectal cancer susceptibility[J]. Oncology, 2002, 16:16 I- 17 I.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部